T. Moller (Leiden, Netherlands), R. Buhl (Mainz, Germany), C. Corrigan (London, United Kingdom), C. Gratziou (Athens, Greece)
The APEX study: A retrospective review of outcomes in patients with severe allergic asthma who were or were not hospitalised in the year prior to omalizumab initiation in UK clinical practice
N. Barnes, A. Mansur, A. Menzies-Gow, A. Radwan, on behalf of the APEX study investigators (London, Birmingham, Frimley/Camberley, United Kingdom)
|  |
Effectiveness of omalizumab in improving quality of life in patients with ‘steroid-resistant‘ asthma and severe allergic rhinitis
B. Omarjee, B. Tanguy (Saint Denis, Reunion)
| |
Population pharmacokinetics of tralokinumab, an investigational anti-IL-13 monoclonal antibody, in asthmatic and healthy adults
P. Baverel, R. Faggioni, B. Agoram (Cambridge, United Kingdom; Hayward, United States Of America)
| |
Cough variant asthma may be a incipience of bronchial asthma
Y. Obase, T. Shimoda, M. Oka, R. Kishikawa, T. Iwanaga (Kurashiki, Fukuoka, Japan)
| |
Effects of budesonide/formoterol combination therapy versus budesonide on airway dimensions in asthma
M. Hoshino (Atami, Japan)
| |
Effects of breast feeding on the prevalence rates of asthma, rhinitis and eczema in Chinese school children
N. Song, M. Shamssain, J. Zhang, S. Hao, J. Wu, C. Fu, X. Yan (Shijiazhuang, China; Sunderland, United Kingdom)
|  |
Effects of water aerosol on pediatric allergic asthma
M. Gaisberger, R. Sanovic, H. Dobias, P. Kolarz, A. Moder, J. Thalhamer, A. Selimovic, I. Huttegger, M. Ritter, A. Hartl (Salzburg, Austria; Belgrade, Republic Of Serbia; Sarajevo, Bosnia And Herzegovina)
| |
Simultaneous analysis of clinical markers for predicting increased lung function fluctability in stable asthma
K. Matsunaga, A. Hayata, T. Hirano, M. Ichinose (Wakayama, Japan)
| |
Impact of allergy diagnosis on patients‘ perceptions and experience of HDM allergy: A European survey
C. Rolland, M. Lheritier-Barrand, L. Tauleigne, M. David, L. Lemonnier, E. Valovirta (Boulogne, Antony, Paris, France; Turku, Finland)
| |
Helminths for asthma: Findings of a Cochrane systematic review
A. Croft, P. Bager, S. Kumar, P. Manning (Lichfield, United Kingdom; Copenhagen, Denmark; Minneapolis, United States Of America; Glasnevin, Ireland)
| |
Changes in total and specific IgE following treatment with mebendazole in patients with persistent asthma and IgE to Ascaris lumbricoides
R. Qualizza, C. Incorvaia, R. Ballerini, R. Grande (Milan, Italy)
| |
High incidence of sinusitis in asthmatic patients detected by computed tomography
K. Yatera, K. Yamasaki, S. Noguchi, M. Hanaka, S. Nagata, C. Nishida, Y. Kawanami, T. Kawanami, H. Ishimoto, H. Mukae (Kitakyushu, Japan)
| |
Chronic paranasal sinusitis exacerbates allergic inflammation in patients with asthma and contributes to refractoriness to treatment
M. Tanaka, T. Okada, H. Watanabe, H. Satoh, S. Tokita, T. Wakayama, K. Kohyama, N. Fueki, H. Sagara (Koshigaya, Japan)
| |
Hospital admission in adults with asthma exacerbations: Do demographic factors play a role?
E. Gerada, J. Micallef, R. Pullicino, M. Gauci, S. Montefort (Msida, Malta)
| |
Efficacy and safety of 300IR 5-grass pollen sublingual tablet in allergic patients with and without asthma
R.K. Zeldin, A. Montagut, J. Cognet-Sicé, K. Abiteboul (Antony, France)
| |
IgE sensitisation to food allergens relates to increased airway and systemic inflammation in asthmatic children – Results from the MIDAS study
A. Malinovschi, C. Janson, M. Berthold, M. Borres, K. Alving, L. Nordvall (Uppsala, Sweden)
| |
The results of inferon administration in the treatment of chronic obstructive pulmonary disease
S. Farkhutdinov, U. Farkhutdinov (Ufa, Russian Federation)
| |
Application of a new mass-spectrometric platform for determination of lipid mediators in urine reveals increased oxidative stress during allergen bronchoprovocation of subjects with atopic asthma
D. Balgoma, K. Daham, J. Larsson, A. Lindeberg, B. Dahlén, J. Rokach, C. Wheelock, S.E. Dahlén (Stockholm, Sweden; Melbourne, United States Of America)
| |
Putting patients at the heart of healthcare: Respiratory allergy care in 18 European countries
E. Valovirta, F. Addeo, D. Finizio, J. Bottema, A.H. Fink-Wagner (Turku, Finland; Fisciano (Sa), Naples, Italy; Amersfoort, Netherlands; Brussels, Belgium)
| |
The effects of inspiratory muscle training on the interleukin-6 response to intense volitional hyperpnoea
D. Mills, M. Johnson, M. McPhillimey, N. Williams, J. Ganzalez, B. Yvonne, S. Graham (Nottingham, Newcastle-upon-Tyne, United Kingdom)
| |